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The following information is provided by FDA/CVM (February 1997)
FDA has received reports that products containing colloidal silver are being promoted for
use in the treatment of mastitis and other serious disease conditions of dairy cattle, as well as for
various conditions of companion animals. For example, FDA’s Center for Veterinary Medicine
has received reports from the Agency's regional milk specialists and State inspectors that colloidal
silver products have been found on some dairy farms. Also, recent articles in some farm
newspapers and journals promote the use of colloidal silver in treating mastitis and claim that no
milk discard is needed.
FDA is not aware of any substantial scientific evidence that supports the safe and effective
use of colloidal silver ingredients or silver salts for any animal disease condition. Also, in the
October 15, 1996 Federal Register, FDA proposed to establish that all over-the-counter human
drug products containing colloidal silver ingredients or silver salts for internal or external use are
not generally recognized as safe and effective and are misbranded. Use of colloidal silver
ingredients in food-producing animals constitutes a potentially serious public health concern
because of the possibility of residues in milk or meat. According to several
scientific publications mentioned in the October 15, 1996, Federal Register proposal, the human
consumption of silver may result in argyria—a permanent ashen-gray or blue discoloration of the
skin, conjunctiva, and internal organs. In addition to the possible human health concerns, use of
these products to treat a serious illness in animals (including pets) could potentially endanger the
health of the animal by delaying timely, appropriate treatment.
Colloidal silver-containing products have not been approved by FDA for use in any animal
species. Promoting the use of colloidal silver for treating animal diseases causes such products to
be misbranded veterinary drugs under the Federal Food, Drug, and Cosmetic Act (the Act).
Labeling colloidal silver products to treat animals causes such products to be new animal drugs
which are adulterated under the Act. FDA has taken action against colloidal silver products, and is
continuing to investigate the promotion and use of colloidal silver products in dairy and other
animals. If necessary, FDA will take further appropriate regulatory action.
Utah State University Extension is an affirmative action/equal employment opportunity employer and educational
organization. We offer our programs to persons regardless of race, color, national origin, sex, religion, age or disability.
Issued in furtherance of Cooperative Extension work, Acts of May 8 and June 30, 1914, in cooperation with the U.S.
Department of Agriculture, Robert L. Gilliland, Vice-President and Director, Cooperative Extension Service, Utah State University,
Logan, Utah.(EP/DF/08/97)

